Newsletter Signup | Join Community
BRAF-MEK-Immunotherapy combination improves survival in stage III and advanced melanoma with V600E and V600K mutations.
Cancer Connect - Treatment of Recurrent Melanoma
5 year follow up continues to demonstrate Yervoy + Opdivo superiority-better understanding of side effects is emerging.
Opdivo anti-PD-1 immunotherapy can be used to treat both stage III and more advanced melanoma.
First degree relatives of individuals with Melanoma are at increased risk of developing skin cancers.
Keytruda treatment for melanoma improves survival, treats CNS disease and may be most effective when used in combination
Ocular melanoma is an uncommon cancer of the eye requiring aggressive treatment by specialized physicians.
Anyone have experience with TVEC? Looking to learn from others. Thanks
A new very active treatment option for Melaoma-Braftovihttps://mavendoctors…